Drug cocktail aims to tame advanced leukemia

NCT ID NCT03895671

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This phase 2 trial is testing whether combining two drugs, ponatinib and 5-azacitidine, can improve survival in people with advanced chronic myeloid leukemia (CML). The study includes adults whose CML has progressed to an accelerated phase or a more aggressive blast crisis. Participants receive both drugs, and researchers track overall survival, safety, and how well the disease responds.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ponatinib and 5-azacitidine
What this could lead to
If successful, this combination could offer a new treatment option for people with advanced chronic myeloid leukemia, potentially improving survival and disease control.
What could go wrong
This is an early-phase trial with a small number of participants. The combination may cause side effects, and it is not yet known if it will be more effective than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Henri Becquerel

    Rouen, France

  • Centre Hospitalier Annecy Genevois

    Pringy, France

  • Centre Hospitalier D'Avignon

    Avignon, France

  • Centre Hospitalier Metropole Savoie

    Chambéry, France

  • Centre Hospitalier Regional Universitaire de Lille

    Lille, France

  • Centre Hospitalier Universitaire D'Amiens

    Amiens, France

  • Centre Hospitalier Universitaire de Clermont Ferrand

    Clermont-Ferrand, France

  • Centre Hospitalier Universitaire de Dijon

    Dijon, France

  • Centre Hospitalier Universitaire de Grenoble

    Grenoble, France

  • Centre Hospitalier Universitaire de Limoges

    Limoges, France

  • Centre Hospitalier Universitaire de Nantes

    Nantes, France

  • Centre Hospitalier Universitaire de Rennes

    Rennes, France

  • Centre Hospitalier de Caen-Normandie

    Caen, France

  • Centre Hospitalier de La Cote Basque

    Bayonne, France

  • Centre Hospitalier de Perpignan

    Perpignan, France

  • Centre Hospitalier de Strasbourg

    Strasbourg, France

  • Centre Hospitalier de Versailles

    Versailles, France

  • Centre Leon Berard

    Lyon, France

  • Chru de Nancy

    Vandœuvre-lès-Nancy, France

  • Hopital Avicenne

    Bobigny, France

  • Hopital Bicetre

    Le Kremlin-Bicêtre, France

  • Hopital Henri Mondor

    Créteil, France

  • Hopital Pitie-Salpetriere

    Paris, France

  • Hopital St Antoine

    Paris, France

  • Hopital St Louis

    Paris, France

  • Hospices Civils de Lyon

    Pierre-Bénite, France

  • Institut Bergonie

    Bordeaux, France

  • Institut Universitaire Du Cancer Toulouse

    Toulouse, France

  • Intitut Gustave Roussy

    Villejuif, France